Paul Y. Song - Dec 6, 2024 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)

Role
Chief Executive Officer
Signature
/s/ Paul Y. Song
Stock symbol
NKGN
Transactions as of
Dec 6, 2024
Transactions value $
$0
Form type
4
Date filed
12/10/2024, 09:56 PM
Previous filing
Feb 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKGN Stock Option (right to buy) Award $0 +2M $0.00 2M Dec 6, 2024 Common Stock 2M $0.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 6, 2024, the Reporting Person was granted 2,000,000 options pursuant to the Company's 2023 Equity Incentive Plan, vesting in 48 equal installments on the sixth of each month, beginning January 6, 2025, and ending December 6, 2028, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.